NORML
OCTOBER 21, 2019
A federal court on Friday denied a petition for a writ of mandamus that sought to order the US Drug Enforcement Administration to begin licensing private entities that wish to cultivate cannabis. The agency in 2016 first announced its intent to license private entities to grow cannabis for FDA-approved clinical trials.
NORML
APRIL 15, 2019
Marijuana grown by the University of Mississippi for clinical research purposes is genetically divergent from strains of cannabis commercially available in retail markets, according to an analysis prepared by researchers at the University of Northern Colorado.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MARCH 30, 2022
Senate Bill 253: The Cannabidiol and Marihuana Research Expansion Act provides the office of US Attorney General, rather than the US Drug Enforcement Administration, the discretion to license scientists to engage in clinical trials involving the use of cannabis by human subjects.
NORML
MARCH 1, 2019
Currently, the sole federally licensed producer of cannabis for clinical research is the University of Mississippi. ” He later acknowledged that these restrictions have led many “companies [to] go overseas to conduct research with foreign-grown product that is more easily sourced for the purposes of clinical trials.”
Cannabis Law Report
NOVEMBER 4, 2021
Drug Enforcement Agency (DEA) to cultivate marijuana for research purposes. In 2016, Dr. Sue Sisley first applied to grow cannabis for research purposes when the Obama administration announced a plan to allow other growers to provide cannabis to researchers. Use the plants for their own studies and/or FDA clinical trials.
The Cannigma
MAY 19, 2021
Some hemp cultivation is permitted in Japan, but on a relatively very small scale. Since 2016, the country has permitted the sale of CBD and some Japanese companies produce cannabidiol products as well. Japanese authorities can prosecute citizens for violating its cannabis laws — even if they used it abroad.
NORML
APRIL 8, 2020
The National Organization for the Reform of Marijuana Laws (NORML) has formally submitted comments to the US Federal Register opposing the Drug Enforcement Administration’s proposed rule changes governing the federal production and distribution of cannabis for clinical research purposes.
Expert insights. Personalized for you.
104 
Let's personalize your content